Adverse Prognosis of Patients with Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease

Circulation

Volumn 108, Issue 19, 2003, Pages 2342-2348

  Sorajja, Paul ^b   Ommen, Steve R ^a   Nishimura, Rick A ^b   Gersh, Bernard J ^b   Berger, Peter B ^b   Tajik, A Jamil ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Cardiomyopathy; Coronary disease; Hypertrophy; Prognosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; STROKE; SURVIVAL RATE;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE TABLES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0242525744     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000097110.55312.BF     Document Type: Article

References (40)

1. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92:785-789.
2. Olivotto I, Cecchi F, Casey S, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517-2524.
3. Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39:301-307.
4. Bensaid J. Idiopathic hypertrophic subaortic stenosis and associated Coronary artery disease: clinical, hemodynamic, and therapeutic features from a review of 57 cases of the literature. Angiology. 1979;30:585-593.
5. Walston A, Behar VS. Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1976;38:12-16.
6. Cokkinos DV, Krajcer Z, Leachman RD. Coronary artery disease in hypertrophic cardiomyopathy. Am J Cardiol. 1985;55:1437-1438.
7. Lardani H, Serrano JA, Villamil RJ. Hemodynamics and coronary angiography in idiopathic hypertrophic subaortic stenosis. Am J Cardiol. 1978;41:476-481.
8. Lazzeroni E, Rolli A, Aurier E, et al. Clinical significance of coronary artery disease in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:499-501.
9. Report of the World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-842.
10. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979;43:1242-1244.
11. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1983;2:437-444.
12. Vlietstra RE, Frye RL, Kronmal RA, et al. Risk factors and angiographic coronary artery disease: a report from the Coronary Artery Surgery Study (CASS). Circulation. 1980;62:254-261.
13. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina. J Am Coll Cardiol. 2002;40:1531-1540.
14. Fuster V, Gotto AM Jr, Libby P, et al. Task Force 1: pathogenesis of coronary disease: the biological role of risk factors. J Am Coll Cardiol. 1996;27:964-976.
15. Oran E, Gupta S, Yeo B, et al. Surgical management of coexisting coronary artery disease and idiopathic hypertrophic subaortic stenosis. Ann Thorac Surg. 1973;16:11-18.
16. Stewart S, Schreiner B. Coexisting idiopathic hypertrophic subaortic stenosis and coronary artery disease: clinical implication and operative management. J Thorac Cardiovasc Surg. 1981;82:278-820.
17. Harjai KJ, Cheirif J, Murgo JP. Ischemia and atherosclerotic coronary artery disease in patients with hypertrophic cardiomyopathy: a review of incidence, pathophysiological mechanisms, clinical implications and management strategies. Coronary Artery Dis. 1996;7:183-187.
18. Anonymous. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation. 1991;84(suppl V):V-1-V-27.
19. Fay WP, Taliercio CP, Ilstrup DM, et al. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol. 1990;16:821-826.
20. McKenna W, Deanfield J, Faruqui A, et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532-538.
21. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102:858-864.
22. Emond M, Mock MB, Davis KG, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation. 1994;90:2645-2657.
23. Elliott PM, Kaski JC, Prasad K, et al. Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J. 1996;17:1056-1064.
24. Dilsizian V, Bonow RO, Epstein SE, et al. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1993;22:796-804.
25. Lazzeroni E, Picano E, Morozzi L, et al. Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Circulation. 1997;96:4268-4272.
26. Yamada M, Elliott PM, Kaski JC, et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy: relationship to clinical presentation and outcome. Eur Heart J. 1998;19:500-507.
27. Tanaka M, Fukiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation. 1987;75:1130-1139.
28. Misawa K, Nitta T, Matsubara T, et al. Difference in coronary blood flow dynamics between patients with hypertension and those with hypertrophic cardiomyopathy. Hypertension Res Clin Exp. 2002;25:711-716.
29. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol. 1998;31:1089-1096.
30. Yetman AT, McCrindle BW, MacDonald C, et al. Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death. N Engl J Med. 1998;339:1201-1209.
31. Choudhury L, Rosen SD, Patel D, et al. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy: a study with positron emission tomography. Eur Heart J. 1997;18:108-116.
32. Krams R, Kofflard MJM, Duncker DJ, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of coronary microcirculation. Circulation. 1998;97:230-233.
33. Hirasaki S, Nakamura T, Kuribayashi T, et al. Abnormal course, abnormal flow, and systolic compression of the septal perforator associated with impaired myocardial perfusion in hypertrophic cardiomyopathy. Ant Heart J. 1999;137:109-117.
34. Kaufmann P, Vassalli G, Lupi-Wagner S, et al. Coronary artery dimensions in primary and secondary left ventricular hypertrophy. J Am Coll Cardiol. 1996;28:745-750.
35. Maron BJ, Wolfson JK, Epstein SE, et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545-557.
36. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilatory reserve and elevated left ventricular filling pressure. Circulation. 1985;71:234-243.
37. Gistri R, Cecchi F, Choudhury L, et al. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol. 1994;74:363-368.
38. Dimitrow PP, Krzanowski M, Bodzon, et al. Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. Heart Vessels. 1996;11:160-164.
39. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775-785.
40. Hecht GM, Panza JA, Maron BJ. Clinical course of middle-aged asymptomatic patients with hypertrophic cardiomyopathy. Am J Cardiol. 1992;69:935-940.